Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Venture capital firm Forbion Capital Partners closes 75-million euros for its co-investment fund

Forbion Capital Partners, the venture capital firm that focusses on life sciences closed a 75 million euros fund for its latest co-investment fund that is aimed at backing later-stage deals in the portfolio of its second flagship fund. Forbion Capital Fund II Co-Invest Fund I will invest in up to six existing FCF II portfolio companies alongside FCF II, in what are likely to be the final financing rounds by these companies before exit. The new co-invest fund has already deployed capital in Cellnovo, which subsequently went public on Euronext Paris and in Dezima Pharma and Exosome Diagnostics.


Fund News,Netherlands,Venture/Growth,co-investment,Forbion Capital Partners,fund,fund close,fundraising,venture capital,forbion capital partners,Cellnovo,Euronext Paris,Dezima Pharma,Exosome Diagnostics